About Us

We are Committed to being a Collaborative Platform for Innovative Biotech Companies from around the World.

Viva BioInnovator ("VBI") is the investment division of Viva Biotech Holdings (1873.HK). We are solely dedicated to the identification and success of early-stage, biotech start-ups for Viva’s incubation, equity-for-service, and investment platforms. Our commitment is to operate a collaborative platform for innovative biotech companies from around the world, and for anyone aiming to develop an idea with transformative or strong potential.

Our Advantages

An Innovative Idea is All You Need


We invest in some of the most innovative founders to build a unique portfolio covering a wide range of indications and drug types.

  • ABM Therapeutics
  • AceLink Therapeutics
  • AcuraStem
  • AmacaThera
  • Anji Pharmaceuticals
  • Arthrosi Therapeutics
  • Basking Biosciences, Inc.
  • Blue Oak Pharmaceuticals
  • Bright Angel Therapeutics
  • Calira Therapeutics
  • Cybrexa Holding Company, LLC
  • Dogma Therapeutics
  • DTx Pharma
  • Elgia Therapeutics
  • Epican Technology
  • Evecxia Therapeutics, Inc.
  • Flash Therapeutics
  • Focus-X
  • Forkhead BioTherapeutics
  • F5 Therapeutics Incorporated
  • Grove Biopharma, Inc.
  • Haya Therapeutics SA
  • I-MAB Biopharma
  • Eubulus
  • Livati Therapeutics
  • Iterion Therapeutics, Inc.
  • Mediar Therapeutics
  • Morphogene SA
  • Nerio Therapeutics
  • Ophidion
  • Path Therapeutics
  • Phenomic AI
  • Proviva
  • QurAlis
  • QureBio
  • Regenacy Pharmaceuticals
  • Reglagene
  • Riparian Pharmaceuticals
  • Saverna Therapeutics
  • Seraxis
  • Sisu Pharma
  • Synthis Therapeutics, Inc.
  • Tabomedex Biosciences
  • Technoderma Medicines
  • Telo Therapeutics, Inc.
  • Totient
  • Trio Bio
  • Triumvira Immunologics
  • United InnoMed
  • VersaPeutics
  • Vincere Biosciences
  • VivaVision
  • Wei Qing biology
  • WMT AG
  • XLement


Read the most up to date information about us and our partners.